Marc Feldmann

Sir
Marc Feldmann
AC
Sir Marc Feldmann AC
Born	2 December 1944 (age 79); Lvov
Citizenship	Australia/United Kingdom
Alma mater	University of Melbourne; Walter and Eliza Hall Institute of Medical Research;
Known for	discovery of anti-TNF therapy for rheumatoid arthritis and other autoimmune diseases
Awards	Crafoord Prize (2000); Cameron Prize for Therapeutics of the University of Edinburgh (2002); Albert Lasker Award for Clinical Medical Research (2003); EPO European Inventor of the Year Award (2007); Dr. Paul Janssen Award for Biomedical Research (2008); Ernst Schering Prize (2010); Gairdner Foundation International Award (2014); Tang Prize (2020) ; Royal Medal (2024);
	Scientific career
Fields	Immunology
Institutions	Kennedy Institute of Rheumatology; Imperial College London; University of Oxford;
Doctoral students	Ashok Venkitaraman

Sir Marc Feldmann, AC FAA FRS FRCP FRCPath FMedSci (born 2 December 1944), is an Australian-educated British immunologist. He is a professor at the University of Oxford and a senior research fellow at Somerville College, Oxford.^[2]

^ Venkitaraman, Ashok Ramakrishnan (1989). The regulation of MHC class 2 gene expression by tumours of the B lymphocyte lineage (PhD thesis). Imperial College London. hdl:10044/1/47696.
^ "Sir Marc Feldmann". Somerville College, Oxford. Retrieved 1 April 2020.

Sir Marc Feldmann AC
Born	(1944-12-02) 2 December 1944 (age 79) Lvov
Citizenship	Australia/United Kingdom
Alma mater	University of Melbourne Walter and Eliza Hall Institute of Medical Research
Known for	discovery of anti-TNF therapy for rheumatoid arthritis and other autoimmune diseases
Awards	Crafoord Prize (2000) Cameron Prize for Therapeutics of the University of Edinburgh (2002) Albert Lasker Award for Clinical Medical Research (2003) EPO European Inventor of the Year Award (2007) Dr. Paul Janssen Award for Biomedical Research (2008) Ernst Schering Prize (2010) Gairdner Foundation International Award (2014) Tang Prize (2020) Royal Medal (2024)
Scientific career
Fields	Immunology
Institutions	Kennedy Institute of Rheumatology Imperial College London University of Oxford
Doctoral students	Ashok Venkitaraman^[1]